Filing Flows › Comparisons › XERS vs INVA
Xeris Biopharma Holdings vs Innoviva: XERS and INVA compared
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $106M for Innoviva (Q3 2026). Xeris Biopharma Holdings is growing faster (+44% against -2% a year earlier). Innoviva is more profitable, with an operating margin of 39.7% against 15.8%.
Where the money goes: XERS and INVA
Xeris Biopharma Holdings (XERS) · Q3 2026
Xeris Biopharma Holdings, Q3 2026: revenue $107M (+44% year over year), operating margin 15.8%, net earnings $11.3M, operating cash flow $35.5M. The chart follows the revenue to costs, profit and cash.
Innoviva (INVA) · Q3 2026
Innoviva, Q3 2026: revenue $106M (-2% year over year), operating margin 39.7%, net loss $73.9M, operating cash flow $41.7M. The chart follows the revenue to costs, profit and cash.
| Xeris Biopharma Holdings (XERS) | Innoviva (INVA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $107M | $106M |
| Revenue growth, Y/Y | +44% | -2% |
| Operating margin | 15.8% | 39.7% |
| Net earnings | $11.3M | −$73.9M |
| Net margin | 10.5% | -69.6% |
| Operating cash flow | $35.5M | $41.7M |
| Free cash flow | — | $41.7M |
Where the revenue comes from
Xeris Biopharma Holdings
- Product revenue, net: $106M (99%)
- Royalty, contract and other revenue: $958K (1%)
Innoviva
- Royalty: $54.7M (52%)
- Product: $49.4M (47%)
- License and Other Revenue: $2.0M (2%)
Questions
Which is bigger, Xeris Biopharma Holdings or Innoviva?
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $106M for Innoviva (Q3 2026).
Is Xeris Biopharma Holdings or Innoviva growing faster?
Xeris Biopharma Holdings is growing faster (+44% against -2% a year earlier).
Which is more profitable, Xeris Biopharma Holdings or Innoviva?
Innoviva is more profitable, with an operating margin of 39.7% against 15.8%.
More: Xeris Biopharma Holdings earnings · how Xeris Biopharma Holdings makes money · Innoviva earnings · how Innoviva makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.